Natural products target glycolysis in liver disease

Shenghao Li(Hebei Medical University), Xiaoyu Hu(Chengdu University of Traditional Chinese Medicine), Liyuan Hao(Chengdu University of Traditional Chinese Medicine)
Frontiers in Pharmacology
August 17, 2023
10.3389/fphar.2023.1242955
Cited by 22

Related Papers

The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease
|Journal of Inflammation Research|2024|61
The current status and future of PD-L1 in liver cancer
|Frontiers in Immunology|2023|55
Antimalarial Dihydroartemisinin triggers autophagy within HeLa cells of human cervical cancer through Bcl-2 phosphorylation at Ser70
|Phytomedicine|2018|52
Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1
|Molecular and Cellular Biochemistry|2020|51
Positive rates of interferon-γ release assay and tuberculin skin test in detection of latent tuberculosis infection: A systematic review and meta-analysis of 200,000 head-to-head comparative tests
|Clinical Immunology|2022|36